HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nils Cordes Selected Research

BIBX 1382BS

11/2007Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nils Cordes Research Topics

Disease

62Neoplasms (Cancer)
01/2022 - 12/2002
18Squamous Cell Carcinoma of Head and Neck
12/2021 - 07/2009
8Glioblastoma (Glioblastoma Multiforme)
10/2021 - 11/2012
7Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 09/2009
7Neoplasm Metastasis (Metastasis)
10/2018 - 01/2007
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2015 - 08/2006
6Head and Neck Neoplasms (Head and Neck Cancer)
10/2020 - 04/2012
5Adenocarcinoma
10/2020 - 09/2009
5Colorectal Neoplasms (Colorectal Cancer)
04/2018 - 12/2002
3Ataxia Telangiectasia (Louis Bar Syndrome)
11/2019 - 05/2010
3Carcinoma (Carcinomatosis)
04/2018 - 03/2004
3Lung Neoplasms (Lung Cancer)
10/2013 - 03/2004
2Glioma (Gliomas)
07/2017 - 06/2013
2Thymoma (Thymic Carcinoma)
11/2007 - 11/2007
2Lymphoma (Lymphomas)
03/2007 - 01/2006
1Rectal Neoplasms (Rectal Cancer)
01/2020
1Prostatic Neoplasms (Prostate Cancer)
10/2018
1Tics (Tic)
01/2016
1Carcinogenesis
04/2015
1Breast Neoplasms (Breast Cancer)
01/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2013

Drug/Important Bio-Agent (IBA)

28IntegrinsIBA
01/2022 - 12/2002
17Proteins (Proteins, Gene)FDA Link
10/2020 - 11/2007
13ErbB Receptors (EGF Receptor)IBA
10/2021 - 08/2006
11DNA (Deoxyribonucleic Acid)IBA
01/2022 - 11/2007
7Cetuximab (Erbitux)FDA Link
04/2018 - 01/2013
61,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
03/2021 - 11/2007
6Phosphotransferases (Kinase)IBA
03/2021 - 01/2007
5Small Interfering RNA (siRNA)IBA
07/2015 - 09/2009
4Protons (Proton)IBA
12/2021 - 10/2020
4Fibronectins (Fibronectin)IBA
01/2018 - 12/2002
4Laminin (Merosin)IBA
01/2017 - 06/2011
4AntibodiesIBA
01/2016 - 01/2007
4Focal Adhesion Protein-Tyrosine KinasesIBA
07/2013 - 09/2009
3Integrin beta1IBA
01/2017 - 03/2007
3ChromatinIBA
01/2012 - 01/2006
3integrin-linked kinaseIBA
07/2009 - 03/2008
2Sirolimus (Rapamycin)FDA Link
10/2021 - 01/2019
2Cell Surface ReceptorsIBA
10/2021 - 12/2013
2Mitogen-Activated Protein KinasesIBA
03/2021 - 11/2007
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2020 - 08/2006
2Tyrosine (L-Tyrosine)FDA Link
10/2020 - 03/2004
2desmuslin (synemin)IBA
10/2020 - 06/2020
2Biomarkers (Surrogate Marker)IBA
01/2020 - 04/2018
2Discoidin Domain Receptor 1IBA
01/2019 - 01/2019
2Indicators and Reagents (Reagents)IBA
01/2017 - 09/2008
2TAE226IBA
04/2015 - 09/2009
2Radiation-Sensitizing AgentsIBA
04/2015 - 10/2013
2Histones (Histone)IBA
10/2013 - 05/2010
2CaspasesIBA
07/2013 - 01/2006
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
07/2013 - 08/2012
2CarbonIBA
06/2013 - 11/2012
2PaxillinIBA
08/2012 - 11/2007
2Caveolin 1IBA
01/2011 - 09/2009
2Pharmaceutical PreparationsIBA
03/2007 - 10/2006
1Harmine (Telepathine)IBA
01/2022
1Therapeutic UsesIBA
01/2022
1Protein Kinases (Protein Kinase)IBA
01/2022
1TOR Serine-Threonine KinasesIBA
10/2021
1Kelch-Like ECH-Associated Protein 1IBA
10/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2019
1Class III Phosphatidylinositol 3-KinasesIBA
01/2019
1Beclin-1IBA
01/2019
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
01/2019
1Regulatory-Associated Protein of mTORIBA
01/2019
1Ethanol (Ethyl Alcohol)IBA
10/2018
1parthenolideIBA
10/2018
1CateninsIBA
04/2018
1Imatinib Mesylate (Gleevec)FDA Link
01/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2015
1Cyclin D1IBA
08/2015
1Growth Factor ReceptorsIBA
04/2015
1SuspensionsIBA
04/2015
1Cell Adhesion MoleculesIBA
02/2015
1tyrosine receptor (receptor, tyrosine)IBA
02/2015
1Matrix Metalloproteinases (MMPs)IBA
01/2015
1Valproic Acid (Depakote)FDA LinkGeneric
01/2015
1Radioisotopes (Radionuclides)IBA
08/2014
1Peptide Hydrolases (Proteases)FDA Link
12/2013
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2013
1Histone Deacetylases (Histone Deacetylase)IBA
10/2013
1DNA-Activated Protein KinaseIBA
10/2013
1Caspase 3 (Caspase-3)IBA
10/2013
1Histone Deacetylase InhibitorsIBA
10/2013
1SurvivinIBA
07/2013
1matrigelIBA
07/2013
1Cyclin-Dependent Kinase 2IBA
07/2013
1Glycogen Synthase KinasesIBA
07/2013

Therapy/Procedure

43Therapeutics
01/2022 - 03/2003
17Radiotherapy
01/2022 - 12/2002
13Drug Therapy (Chemotherapy)
01/2019 - 11/2007
3Chemoradiotherapy
07/2017 - 12/2013
2Combined Modality Therapy
10/2021 - 01/2016
2Cell- and Tissue-Based Therapy (Cell Therapy)
10/2020 - 01/2017
2Aftercare (After-Treatment)
01/2016 - 12/2013
1Proton Therapy
03/2021
1Precision Medicine
01/2020
1Radioimmunotherapy
03/2013